Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishing Evidence-based Multicomponent Treatment for Speech and Language in Primary Progressive Aphasia

NCT06649084 is registered in ClinicalTrials.gov with University of Texas at Austin as lead sponsor.

NCT NCT06649084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06649084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishing Evidence-based Multicomponent Treatment for Speech and Language in Primary Progressive Aphasia
Lead sponsor
University of Texas at Austin
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
May 2, 2023
Completion date
December 31, 2025
Enrollment
21 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aphasia, aphasia, progressive, logopenic progressive aphasia, nonfluent aphasia, progressive, primary progressive aphasia, semantic dementia, semantic memory disorder